Comment
doi: 10.7326/M19-2475.
Epub 2019 Sep 17.
Individualize Treatment With Aspirin for Primary Prevention
Affiliations
- PMID: 31525772
- DOI: 10.7326/M19-2475
Item in Clipboard
Comment
Individualize Treatment With Aspirin for Primary Prevention
Ann Intern Med.
.
No abstract available
Comment on
-
Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.Ann Intern Med. 2019 Oct 15;171(8):529-539. doi: 10.7326/M19-1132. Epub 2019 Sep 17. Ann Intern Med. 2019. PMID: 31525775
Similar articles
-
Aspirin for Primary Prevention: Clinical Considerations in 2019.JAMA. 2019 Jan 22;321(3):253-255. doi: 10.1001/jama.2018.20577. JAMA. 2019. PMID: 30667488 No abstract available.
-
[Aspirin for primary cardiovascular prevention : the end of an era ?].Rev Med Suisse. 2020 Mar 4;16(684):459-462. Rev Med Suisse. 2020. PMID: 32134226 Review. French.
-
Review: In newer CVD primary prevention trials, aspirin vs no aspirin does not reduce MI and increases major bleeding.Ann Intern Med. 2019 Nov 19;171(10):JC55. doi: 10.7326/ACPJ201911190-055. Ann Intern Med. 2019. PMID: 31739338 No abstract available.
-
Aspirin for the primary prevention of cardiovascular disease: a comprehensive review.Compr Ther. 2005 Fall;31(3):186-93. doi: 10.1385/comp:31:3:186. Compr Ther. 2005. PMID: 16110127 Review.
-
Aspirin for primary prevention: do potential benefits outweigh the risks?Intern Med J. 2009 Jun;39(6):401-7. doi: 10.1111/j.1445-5994.2008.01888.x. Intern Med J. 2009. PMID: 19580619 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
